[AMRX] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
02-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 87.88%
YoY- -266.42%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 519,294 464,662 498,533 397,328 378,283 404,642 446,120 10.62%
PBT -21,889 -21,758 13,344 -57,111 26,276 -56,227 -133,180 -69.89%
Tax 144 2,186 -108,173 7,792 389,668 -5,701 -8,428 -
NP -8,975 -11,996 115,067 -32,128 -265,006 -16,902 -47,881 -67.14%
Tax Rate - - 810.65% - -1,482.98% - - -
Total Cost 528,269 476,658 383,466 429,456 643,289 421,544 494,001 4.55%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -1.73 -2.58 23.08 -8.09 -70.05 -4.18 -10.73 -70.27%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.06 -0.08 0.78 -0.23 -2.03 -0.13 -0.37 -70.16%
EPS Diluted -0.06 -0.08 0.78 -0.23 -2.03 -0.13 -0.37 -70.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.